Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05935748 |
| Title | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | NiKang Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California San Diego | La Jolla | California | 92093 | United States | Details | |
| Northwestern University - Feinberg School of Medicine | Chicago | Illinois | 60611 | United States | Details | |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| University of Michigan-Rogel Cancer Center | Ann Arbor | Michigan | 48109 | United States | Details | |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065-6094 | United States | Details | |
| UT Southwestern Medical Center | Dallas | Texas | 75390-9324 | United States | Details | |
| University of Virginia Health System | Charlottesville | Virginia | 22908 | United States | Details |